About Myomo, Inc.
https://www.myomo.comMyomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
CEO
Paul R. Gudonis
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-01-31 | Reverse | 1:30 |
ETFs Holding This Stock
Summary
Showing Top 3 of 40
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
ROSALIND ADVISORS, INC.
Shares:3.79M
Value:$3.54M
HERR INVESTMENT GROUP LLC
Shares:2.85M
Value:$2.66M
BLACKROCK, INC.
Shares:1.66M
Value:$1.55M
Summary
Showing Top 3 of 70
About Myomo, Inc.
https://www.myomo.comMyomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $10.09M ▲ | $9.96M ▼ | $-3.66M ▲ | -36.3% ▲ | $-0.09 ▲ | $-3.08M ▲ |
| Q2-2025 | $9.65M ▼ | $10.64M ▲ | $-4.63M ▼ | -47.99% ▼ | $-0.11 ▼ | $-4.16M ▼ |
| Q1-2025 | $9.83M ▼ | $10.13M ▲ | $-3.47M ▼ | -35.24% ▼ | $-0.08 ▼ | $-3.07M ▼ |
| Q4-2024 | $12.07M ▲ | $8.86M ▲ | $-260.08K ▲ | -2.16% ▲ | $-0.01 ▲ | $220.72K ▲ |
| Q3-2024 | $9.21M | $7.9M | $-966.41K | -10.5% | $-0.03 | $-836.34K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $12.55M ▼ | $34.08M ▼ | $19.45M ▼ | $14.63M ▼ |
| Q2-2025 | $15.48M ▼ | $38.67M ▼ | $21.06M ▲ | $17.62M ▼ |
| Q1-2025 | $21.52M ▼ | $40.87M ▼ | $19.18M ▲ | $21.69M ▼ |
| Q4-2024 | $24.87M ▲ | $42.24M ▲ | $17.53M ▲ | $24.71M ▲ |
| Q3-2024 | $6.62M | $16.31M | $7.02M | $9.29M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.66M ▲ | $-1.83M ▲ | $189.7K ▲ | $-50K ▼ | $-1.69M ▲ | $-2.88M ▲ |
| Q2-2025 | $-4.63M ▼ | $-8.87M ▼ | $-757.35K ▲ | $4M ▲ | $-5.55M ▼ | $-10.12M ▼ |
| Q1-2025 | $-3.47M ▼ | $-2.68M ▼ | $-1.9M ▼ | $-36.51K ▼ | $-4.58M ▼ | $-3.35M ▼ |
| Q4-2024 | $-260.08K ▲ | $3.37M ▲ | $-1.35M ▼ | $15.77M ▲ | $17.75M ▲ | $2.51M ▲ |
| Q3-2024 | $-966.41K | $-1.49M | $2.83M | $-199.5K | $1.15M | $-1.81M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 |
|---|---|---|---|---|
 Product | $10.00M ▲ | $10.00M ▲ | $20.00M ▲ | $10.00M ▼ |
CEO
Paul R. Gudonis
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-01-31 | Reverse | 1:30 |
ETFs Holding This Stock
Summary
Showing Top 3 of 40
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
ROSALIND ADVISORS, INC.
Shares:3.79M
Value:$3.54M
HERR INVESTMENT GROUP LLC
Shares:2.85M
Value:$2.66M
BLACKROCK, INC.
Shares:1.66M
Value:$1.55M
Summary
Showing Top 3 of 70